GEN - Genetic Engineering and Biotechnology News
WEBGet the latest news and information on genetic engineering and biotechnology including analysis, features, webinars, podcasts, and more.
Danaher Delivers: Cytiva, Pall Plan $1.5B Manufacturing Expansion
WEBAug 2, 2021 · Cytiva and Pall plan to hire 2,000 full-time employees over the next two years. COVID-19 drug and vaccine production has been among key drivers of growth for Danaher’s Life Sciences segment.
Top 10 Sequencing Companies
WEBApr 9, 2018 · By 2022, the global next-generation sequencing (NGS) market has been projected to reach between $10.5 billion (BCC Research) and $12.45 billion (MarketsandMarkets), though a more cautious forecast ...
Top 25 Biotech Companies of 2024 - genengnews.com
WEBJan 12, 2024 · Just missing the list at number 26 is BioMarin Pharmaceutical, which had a market cap of $17.51 billion on December 8, followed by WuXi Biologics ($15.94 billion), UCB ($15.52 billion), Novozymes ...
About GEN
WEBMeet the GEN Team. Genetic Engineering & Biotechnology News (GEN) is the flagship publication of Mary Ann Liebert, Inc. Celebrating its 40 th anniversary in 2021, GEN was the first publication in ...
Top 10 Contract Development and Manufacturing Organizations
WEBSep 15, 2023 · 10. MilliporeSigma. • Announced a $25 million expansion of its Lenexa, KS, facility that will add 98,000 square feet of laboratory and production space for manufacturing cell culture media ...
Top 25 Biotech Companies of 2023 - genengnews.com
WEBMay 5, 2023 · The biggest one-year decliner (down 40.2%) was Direxion Daily S&P Biotech Bull 3X Shares (LABU), the fifth-largest ETF with about $1.064 billion in total assets (dropping from $9.14 to $5.47). Yet ...
Agilent and UC San Diego Launch Center of Excellence in Cellular ...
WEBApr 2, 2024 · Agilent Technologies and the University of California San Diego agreed to collaborate to establish the Agilent Center of Excellence (CoE) in Cellular Intelligence, which is located at UC San Diego ...
Top 10 Companies Leveraging Gene Editing in 2018
WEBAug 27, 2018 · The five include EDIT-101, a genome-editing treatment candidate for Leber Congenital Amaurosis type 10 (LCA10) that Allergan plans to develop and commercialize, the companies said earlier this ...
PerkinElmer Adds Cell Engineering Tools with $383M Horizon …
WEBNov 2, 2020 · At $385 million, the deal values Horizon shares at 185 pence ($2.39)—more than double its Friday closing price of 88.8 pence ($1.15), and a 95% premium to the stock’s three-month weighted ...